Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram

被引:0
|
作者
Ibrahim Karabayir
Fatma Gunturkun
Liam Butler
Samuel M. Goldman
Rishikesan Kamaleswaran
Robert L. Davis
Kalea Colletta
Lokesh Chinthala
John L. Jefferies
Kathleen Bobay
G. Webster Ross
Helen Petrovitch
Kamal Masaki
Caroline M. Tanner
Oguz Akbilgic
机构
[1] Medical Center Boulevard,Cardiovascular Section, Department of Internal Medicine, Wake Forest School of Medicine
[2] Stanford University,Quantitative Sciences Unit, Department of Medicine
[3] University of California-San Francisco,Division of Occupational, Environmental, and Climate Medicine, San Francisco Veterans Affairs Medical Center
[4] Emory University,Department of Biomedical Informatics
[5] University of Tennessee Health Science Center,Center for Biomedical Informatics
[6] Edward Hines Jr. VA Hospital,Department of Neurology
[7] University of Tennessee Health Science Center,Department of Preventive Medicine
[8] Loyola University Chicago,Parkinson School of Health Sciences and Public Health
[9] Veterans Affairs Pacific Islands Health Care Systems,Department of Geriatric Medicine, John A. Burns School of Medicine
[10] Pacific Health Research and Education Institute,Department of Neurology, Weill Institute for Neurosciences
[11] Kuakini Medical Center,undefined
[12] University of Hawaii,undefined
[13] University of California San Francisco,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Little is known about electrocardiogram (ECG) markers of Parkinson’s disease (PD) during the prodromal stage. The aim of the study was to build a generalizable ECG-based fully automatic artificial intelligence (AI) model to predict PD risk during the prodromal stage, up to 5 years before disease diagnosis. This case–control study included samples from Loyola University Chicago (LUC) and University of Tennessee-Methodist Le Bonheur Healthcare (MLH). Cases and controls were matched according to specific characteristics (date, age, sex and race). Clinical data were available from May, 2014 onward at LUC and from January, 2015 onward at MLH, while the ECG data were available as early as 1990 in both institutes. PD was denoted by at least two primary diagnostic codes (ICD9 332.0; ICD10 G20) at least 30 days apart. PD incidence date was defined as the earliest of first PD diagnostic code or PD-related medication prescription. ECGs obtained at least 6 months before PD incidence date were modeled to predict a subsequent diagnosis of PD within three time windows: 6 months–1 year, 6 months–3 years, and 6 months–5 years. We applied a novel deep neural network using standard 10-s 12-lead ECGs to predict PD risk at the prodromal phase. This model was compared to multiple feature engineering-based models. Subgroup analyses for sex, race and age were also performed. Our primary prediction model was a one-dimensional convolutional neural network (1D-CNN) that was built using 131 cases and 1058 controls from MLH, and externally validated on 29 cases and 165 controls from LUC. The model was trained on 90% of the MLH data, internally validated on the remaining 10% and externally validated on LUC data. The best performing model resulted in an external validation AUC of 0.67 when predicting future PD at any time between 6 months and 5 years after the ECG. Accuracy increased when restricted to ECGs obtained within 6 months to 3 years before PD diagnosis (AUC 0.69) and was highest when predicting future PD within 6 months to 1 year (AUC 0.74). The 1D-CNN model based on raw ECG data outperformed multiple models built using more standard ECG feature engineering approaches. These results demonstrate that a predictive model developed in one cohort using only raw 10-s ECGs can effectively classify individuals with prodromal PD in an independent cohort, particularly closer to disease diagnosis. Standard ECGs may help identify individuals with prodromal PD for cost-effective population-level early detection and inclusion in disease-modifying therapeutic trials.
引用
收藏
相关论文
共 50 条
  • [21] Externally Validated Deep Learning Model for Patent Ductus Arteriosus Detection by Echocardiography in Preterm Infants
    Gearhart, Addison
    Elrod, Micaela
    Gomes, Thomas
    Golbus, Alexa
    Baltimore, Christopher
    Wakser, Cayla
    Graham, Jason
    Lai, Wyman
    Powell, Andrew
    Smith, Dane
    Baker, George
    CIRCULATION, 2024, 150
  • [22] Deep Learning Algorithm of 12-Lead Electrocardiogram for Parkinson Disease Screening
    Yoo, Hakje
    Chung, Se Hwa
    Lee, Chan-Nyoung
    Joo, Hyung Joon
    JOURNAL OF PARKINSONS DISEASE, 2023, 13 (01) : 71 - 82
  • [23] Prodromal Parkinson's disease and subsequent risk of Parkinson's disease and mortality
    Chen, Xiao
    Li, Yaqi
    Shen, Yun
    Schwarzschild, Michael A.
    Gao, Xiang
    NPJ PARKINSONS DISEASE, 2025, 11 (01)
  • [24] ECG-AI: AN EXTERNALLY VALIDATED DEEP LEARNING MODEL TO PREDICT HEART FAILURE RISK
    Akbilgic, Oguz
    Butler, Liam
    Karabayir, Ibrahim
    Kitzman, Dalane W.
    Clifford, Gari
    Chen, Lin Yee
    Alonso, Alvaro
    Chang, Patricia P.
    Soliman, Elsayed Z.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 328 - 328
  • [26] Editor's note: Prodromal Parkinson's disease
    Obeso, Jose A.
    MOVEMENT DISORDERS, 2019, 34 (05) : 664 - 664
  • [27] Cognition and the Course of Prodromal Parkinson's Disease
    Weintraub, Daniel
    Chahine, Lana M.
    Hawkins, Keith A.
    Siderowf, Andrew
    Eberly, Shirley
    Oakes, David
    Seibyl, John
    Stern, Matthew B.
    Marek, Kenneth
    Jennings, Danna
    MOVEMENT DISORDERS, 2017, 32 (11) : 1640 - 1645
  • [28] On the Emergence of Tremor in Prodromal Parkinson's Disease
    Fearon, Conor
    Lees, Andrew J.
    McKinley, John J.
    McCarthy, Allan
    Smyth, Shane
    Farrell, Michael
    Lynch, Timothy
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (01) : 261 - 269
  • [29] Neuropsychological impairment in prodromal Parkinson's disease
    Pausch, Christoph
    Schomburg, Robert
    Wagenpfeil, Stefan
    Wollenweber, Frank Arne
    Bayer, Caroline
    Fassbender, Klaus
    Behnke, Stefanie
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 371 : 117 - 120
  • [30] Biofluid Biomarkers in Prodromal Parkinson's Disease
    Mollenhauer, B.
    Chahine, L.
    Dakna, M.
    Bartl, M.
    Siderowf, A.
    Hutten, S. J.
    Merchant, K.
    Marek, K.
    Galasko, D.
    MOVEMENT DISORDERS, 2021, 36 : S339 - S339